$VSEE

VSEE HEALTH, INC.

VSee Health provides telehealth software and clinical services through its wholly owned subsidiaries, VSee Lab and iDoc. VSee Lab offers U.S. hospitals and enterprises a configurable platform with software building blocks, data connectors and workflow templates for virtual visits, scheduling, patient engagement, clinician coordination, remote exams and monitoring, payments, records and analytics. Its no-code and low-code tools let healthcare organizations tailor workflows and connect with electronic medical record systems. The company serves health systems and other healthcare enterprises. Through iDoc, VSee Health provides intensive care physician services, including neurology, cardiac and medical ICU coverage, as well as specialty e-consultations for correctional facilities. Its customers include hospital systems, smaller hospitals, long-term acute care facilities and the federal prison system. It earns money from its telehealth platform and clinical services. VSee Health is headquartered in Boca Raton, Florida.

0
0
1

No SEC Form 4 filings for $VSEE in the last 30 days.

See all $VSEE insider activity →
Med

VSee Health 3Q 2026: Revenue $1.5M, EPS ($3.88) — 10-Q Summary

VSee Health reported 3Q 2026 revenue of $1.5M, down 35% YoY, and a net loss of $2.85M, widened from $289.75K. EPS was ($3.88). The decline was driven by a shift to lower-margin teleradiology and contract expirations in Tele-ICU and Virtual Neuro services.

VSee Health Shareholder Letter

VSee Health (Nasdaq:VSEE) reported progress in its strategic transformation, focusing on its hospital-focused telehealth business, iDoc. The company aims to double revenue and achieve profitability in 2027, while exploring M&A opportunities. VSee plans to move to the OTCQB market and seeks future reinstatement on NASDAQ or NYSE. Revenue from continuing operations grew in the first half of 2026 compared to the same period last year.

VSEE sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning VSEE (VSEE HEALTH, INC.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.

Recent VSEE coverage spans corporate actions, financial news and earnings.

What's driving VSEE

AlphAI scores every news story that mentions VSEE with an AI model for sentiment and relevance, and aggregates insider trades from VSEE HEALTH, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $VSEE

Score

VSee Health Shareholder Letter

VSee Health (Nasdaq:VSEE) reported progress in its strategic transformation, focusing on its hospital-focused telehealth business, iDoc. The company aims to double revenue and achieve profitability in 2027, while exploring M&A opportunities. VSee plans to move to the OTCQB market and seeks future reinstatement on NASDAQ or NYSE. Revenue from continuing operations grew in the first half of 2026 compared to the same period last year.

$VSEELowDebt financing· $180.55K

VSEE HEALTH, INC. (VSEE): Entry into a Material Definitive Agreement

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into Material Definitive Agreement. Additional Vanquish Convertible Note Financing As previously reported, on June 18, 2026, VSee Health, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Vanquish SPA”) with an instit

$VSEEMedOffering· $5M · proposed

VSEE HEALTH, INC. (VSEE): Entry into a Material Definitive Agreement

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into Material Definitive Agreement. Strata Agreement On September 2, 2026, VSee Health, Inc., a Delaware corporation (the “Company”), executed a Strata Purchase Agreement (the “Strata Agreement”) with Clearthink Capital Partners, LLC (“Clearthink”). Pursuant to th

$VSEELowExec change· resigned

VSEE HEALTH, INC. (VSEE): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers On August 27, 2026, Scott Metzger resigned, effective immediately, as a member of the Board of Directors (the “Board”) of VSe

$VSEELowShareholder vote

VSEE HEALTH, INC. (VSEE): Submission of Matters to a Vote of Security Holders

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07 Submission of Matters to a Vote of Security Holders. On August 25, 2026, VSee Health, Inc., a Delaware Corporation (the “Company”), held its annual meeting of stockholders for its fiscal year ended December 31, 2026 (the “Annual Meeting”). As of July 6, 2026, the record

VSee Health to Acquire $35M Healthcare Commerce Platform

VSee Health, Inc. signed a non-binding LOI to acquire healthcare technology and operating assets valued at about $42 million. The target supports a clinic-based wellness commerce platform with an unaudited annual revenue run rate over $35 million and about $7 million in EBITDA. VSee says it would integrate ordering and payment workflows into its API virtual care platform, subject to due diligence and approvals.

$VSEEMedDebt financing· $336K

VSEE HEALTH, INC. (VSEE): Entry into a Material Definitive Agreement

VSEE HEALTH, INC. (VSEE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Labrys Convertible Promissory Note Financing On June 30, 2026, VSee Health, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Labrys SPA”) with an institutional investor (“Labrys”

Related tickers